ReShape Lifesciences Inc (RSLS) USD0.001

Sell:$2.61Buy:$2.67$0.20 (6.97%)

Prices delayed by at least 15 minutes
Sell:$2.61
Buy:$2.67
Change:$0.20 (6.97%)
Prices delayed by at least 15 minutes
Sell:$2.61
Buy:$2.67
Change:$0.20 (6.97%)
Prices delayed by at least 15 minutes

Company Information

About this company

ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The Diabetes Bloc-Stim Neuromodulation system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0 FLEX, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Key people

Dan W. Gladney
Executive Chairman of the Board
Paul F. Hickey
President, Chief Executive Officer, Director
Thomas Stankovich
Chief Financial Officer
Lori Courtney Mcdougal
Independent Director
Arda Minocherhomjee
Independent Director
Click to see more

Key facts

  • EPIC
    RSLS
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US76090R4083
  • Market cap
    $6.85m
  • Employees
    17
  • Shares in issue
    2.39m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.